Etravirine as a culprit of recurrent drug-eluting in-stent restenosis in an HIV patient

Int J Cardiol. 2016 Sep 15:219:117-8. doi: 10.1016/j.ijcard.2016.06.008. Epub 2016 Jun 11.

Authors

Gaurav K Sharma¹, Michael Megaly²

Affiliations

¹ The Department of Internal Medicine, Mercy Hospital and Medical Center, Chicago, IL, United States. Electronic address: [email protected].
² The Department of Internal Medicine, Mercy Hospital and Medical Center, Chicago, IL, United States.

PMID: 27318755
DOI: 10.1016/j.ijcard.2016.06.008

No abstract available

Keywords: Clopidogrel; Coronary artery disease; Etravirine; HIV; In-stent restenosis.

Publication types

Case Reports

MeSH terms

Clopidogrel
Coronary Restenosis / blood
Coronary Restenosis / chemically induced*
Coronary Restenosis / diagnosis
Drug Interactions / physiology
Drug-Eluting Stents / adverse effects*
Female
HIV Infections / blood
HIV Infections / drug therapy*
HIV Infections / surgery*
Humans
Middle Aged
Nitriles
Pyridazines / adverse effects*
Pyridazines / blood
Pyrimidines
Ticlopidine / analogs & derivatives*
Ticlopidine / blood
Ticlopidine / therapeutic use

Substances

Nitriles
Pyridazines
Pyrimidines
etravirine
Clopidogrel
Ticlopidine